MEMBER LOG-IN

LOGIN HELP

LogIn Help

SIGN UP

CLICK TO CREATE AN ACCOUNT
JOIN US or FOLLOW US HERE go to linkedIn go to twitter

New Account Registration

Yes No

Please sign me up for these other regions too:

BIO Europe BioBreak
New Jersey BioBreak
Philly BioBreak
Utah BioBreak
JPMorgan BioBreak
Boston BioBreak
UK BioBreak
Big BIO BioBreak
New York BioBreak
Sweden BioBreak
All Regions
Yes No
I agree with BioBreak's Privacy Policy

Refer a Friend

Reset Password

Boston BioBreak – Events Archive

Please see below for attendees and images from this event.

Boston Boston BioBreak Networking Happy Hour October 25, 2018 5:30-7:30 pm

Attendees at this event

Geoff Meyerson Locust Walk
Mahmoud Mahmoudian Boston BioMedical
Jamil Beg 5AM Ventures
Jordan Leef Pyramid Biosciences Inc
Doug Carlson Collegium Pharmaceutical
Jeff Behrens Siamab Therapeutics
Ted Hibben Catabasis Pharmaceuticals
John Ripple Exonics Therapeutics
Imran Nasrullah Boehringer-Ingelheim
Greg Miller Visterra
Catherine Lenich Beth Israel Deaconess Medical Center
Yukari Perrella Yuma Therapeutics
Kleem Chaudhary Biogen
Marcelo Cheresky Bioverativ
Douglas MacDougall MacDougall Biomedical Communications
Catherine Thut Novartis Institutes for BioMedical Research
Brad Carver SynDevRx
Rick Lundberg Navitor Pharmaceuticals
Adam Muzikant Flexion Therapeutics
Eric Elenko PureTech Ventures
Jonathan Behr JDRF T1D Fund
Scott Requadt Clarus Ventures
David Brush Novartis Institutes for BioMedical Research
Caleb Moore Acceleron Pharma
Barbara Fox Tilos Therapeutics
Leslie Williams ImmusanT
Mark Fraga Shire
Avi Spier Novartis
John Schwartz AcuityBio
Jeff Imbaro Semma Therapeutics
Ed Mascioli EMMD LLC
Arthur Hiller Antyllus Therapeutics
Scott Edwards SciFluor Life Sciences
Markus Haeberlein Alkermes
Antony Newton Personal Genome Diagnostics
Helen Ho Blueprint Medicines
Grant Zimmermann Harvard University
Andy Meyerson Locust Walk
Jens Eckstein SR One
Ben Askew Scifluor Life Sciences
Michael Boretti Epizyme
Kees Been Lysosomal Therapeutics
Ryan Dietz Boston Children's Hospital
Minji Kim Jounce
John Tagliamonte WntRx
Chris Kim Novatio Ventures
John Delyani Tmunity
Neil Swami MVM Life Sciences Partners
Nick DeLong Locust Walk
Tanja-Stephanie Weber Agios
James Shanahan SynDevRx, Inc.
Alexander Pickett Mediqventures, Ltd.
Ton Bunt Izumi Biosciences
Rich Howlett Keros Therapeutics
Bob Palladino Bionevia LLC
James Gorman Startup Mode
Wayne Foster Mersana Therapeutics, Inc.
Adam McNulty Chiesi Group
David Standring
Walter Olesiak Remiges Ventures
Maude Tessier Kyn Therapeutics
Roman Fleck Janpix
Mark Stencik Merck
Gaye Bok Orionis Biosciences Inc.
Derek Yoon AJU IB Investment
Patrick Tricoli NANOBIOTIX US
Christo Shalish Moderna
Stephen Seiler Baxalta
Vicki Morgan viDA Therapeutics
Andrew meadow Excelyrate Capital
Tarik Soliman Extend Biosciences
Girish Aakalu Ipsen
Chris Gemmiti Sentien Biotech
Guillermo Rubio AMAG Pharmaceuticals
Jennifer Wheler TScan Therapeutics
Catherine Nuccio Alexandria Venture Investments
Shaan Gandhi Longwood Fund
Christopher Scannell Akrivis
Scott Fishman Envisage
Stephen Curtis MPM Capital
Dilip Paithankar Sebacia
Gladys Nunez Amgen
Ted Marple Acworth Pharmaceuticals, Inc.
Darren Braccia Lysosomal Therapeutics
David Sherris GenAdam Therapeutics
Elaine Wong RA Capital
Bob Linke Embera NeuroTherapeutics
Alex Shlyankevich Millhouse
Jie Liu Torreya Partners
Ed Addison Cloud Pharmaceuticals
Kollol Pal Pyramid Biosciences
Katie Ellias JDRF T1d Fund
Matthew Hawryluk Gritstone Oncology
Julia Keith RA Capital
Yury Kukushkin 4biocapital
Manav Mehta Gel4Med
Karen Nelson Novartis
Kate Rumrill NeoSync, Inc.
Stefano Gulla Abcuro
Barbara Sosnowski Pfizer
Ben Thorner Merck
Maria Zlyhastseva BioBreak
Patrick Rivelli MIT Angels
Jim Ellis Carica Health
Diala Ezzeddine Xios Therapeutics
Alan Ginsberg Shire
Anthony Walsh BioInnovation Capital
Lucas de Breed INKEF Capital
Cheryl Wood Adare Pharmaceuticals
Laura Stoppel RA Capital Management
Meg Krench RA Capital Management
Lisa McKerracher BioAxone Biosciences Inc.
Eric Evans Mass Medical Angels
Evan Thompson Abcuro
Shawn Marcell ReadCoor
Komal Joshi Jounce Therapeutics
Jeff Stevens Puretech Health
Larry Cai Fosun
Jason Ruth 5AM Ventures
Nevin M. Summers MIT Synthetic Biology Center
Doris Peterkin OncoPep, Inc.
Benjamin Sigel Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
Kerrie Brady Cetrexion Therapeutics
Victor Shifrin ImmunoChem Therapeutics
Jin Ji PulchriBio
Christopher Roberts Princeps Therapeutics
John Dellapa Mintz Levin
Rosy Hu Partners Innovation Fund
Melissa BradfordKlug Keryx
Alex Nichols Mythic Therapeutics
James Jogerst Berg Health
Adam Buckley VBI Vaccines Inc
Kim Seth Repare Therapeutics
Kathryn McAllister Merck
Fred Chereau LogicBio
Tom Wilton LogicBio
Devin Quinlan MPM Capital
Seiji Nakano Asahi Kasei - Healthcare
John Parker Springhood Ventures
Lori Kaiser Halloran Consulting Group
Marion Hitchcock Bayer
Barbara Hibner PercepTx
Christine Foster Acceleron Pharma
Paul Jaminet Angiex Inc
Sylvie Peltier Servier
Alex Ray Boston Millennia Partners
Sabrina Yang Flagship Pioneering
Thomas Collet Phrixus Pharmaceuticals, Inc.
Bernhard Guenther Novaliq Inc.
Theonie Anastassiadis Flagship Pioneering
Luba Greenwood Google
Benjamin Kreitman Broadview Ventures
Mike Luther Bantam Pharmaceutical, LLC
Baruch Harris Metera
Lee Cooper Enlight Bio
JS CLEIFTIE erytech pharma
Christopher Gagliardi Sanofi Ventures
Melissa McCracken Third Rock Ventures
Kelly Moynihan Third Rock Ventures
Nicholas McCray Sanofi
Uciane Scarlett Atlas Venture
Michael Goldberg STIMIT
Loic VINCENT Takeda
Samuel Murphy Salubris Pharma
Andrew Senesi RA Capital
Lance Ostrom Roche
Jamie Kasuboski Boehringer Ingelheim Venture Fund
Markus Renschler Cyteir Therapeutics
Brian Fenton Translate Bio
rosemary harrison RA Capital
Rajeev Chillakuru Elstar Therapeutics, Inc
Jaideep Dudani Vida Ventures
Adam Friedman Vivid Biosciences
Cheryl Nickerson-Nutter Hulow Medical
Alex Harding Atlas Venture
Frederic Sweeney Northern Biologics
John Hennessey Boston Harbor Angels
Adrian Tristan MicroQuin
Philip Strandwitz Holobiome, Inc
Mike Santos Cocoon Biotech, Inc.
Ross Castillo JDRF T1D Fund
Christina Hedberg MIT TLO
Paul Young Merck
Elizabeth Reczek Ravello Precision Partners
Chris Gackstatter VC23
Nicholas McCray Sanofi-Genzyme
Maria vilenchik Felicitex Therapeutics, Inc.
Jonathan Friedlander Digitalis
Christine Bunt Verseau Therapeutics
Stan Wang Cellino Biotech, Inc.
David Lee Servier Pharmaceuticals

Become a Supporter

For more information about sponsorship, please email us at sponsorship@biobreak.org.

Web design: GillFishmanDesign.com